TSCAN THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-17.1M | $42.4M |
| FY2020 | — | $-42.5M | $34.8M |
| FY2021 | — | $160.8M | $161.4M |
| FY2022 | $29.3M | $99.4M | $120.0M |
| FY2023 | $26.7M | $150.9M | $133.4M |
| FY2024 | $32.1M | $241.0M | $178.7M |
| FY2025 | $32.5M | $123.1M | $152.4M |